LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

Home・Aandelen Lijst・Medpace Holdings Inc

Medpace Holdings Inc

Gesloten

SectorGezondheidszorg

421.86 1.03

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

411.69

Max

424.21

Belangrijke statistieken
By Trading Economics
Inkomsten	-11M 124M
Verkoop	-1.8M 707M
K/W Sectorgemiddelde	26.245 51.415
EPS	4.28
Winstmarge	17.53
Werknemers	6,300
EBITDA	-16M 148M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+6.61% upside

Dividenden
By Dow Jones
Volgende Winsten	20 jul 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-3.2B 12B
Vorige openingsprijs	420.83
Vorige sluitingsprijs	421.86

Nieuwssentiment

By Acuity

100%

329 / 346 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

300 / 302.88 Steun & Weerstand

Medpace Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 okt 2025, 15:15 UTC

Winsten

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Vergelijking

Prijswijziging

Medpace Holdings Inc Prognose

Koersdoel

By TipRanks

6.61% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 447.5 USD 6.61%

Hoogste 495 USD

Laagste 393 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Medpace Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Gebaseerd op 8 analisten die aandelenratings hebben gegeven aan Medpace Holdings Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

300 / 302.88Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

329 / 346 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.